Profil bibliographique

Pier Luigi Zinzani

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

6Publications signalées

0Citations signalées

4Affiliations récentes

Institutions déclarées

IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola Azienda USL di Bologna Istituto Oncologico Romagnolo University of Bologna

Domaines associés

Lymphoma Diagnosis and TreatmentMonoclonal and Polyclonal Antibodies ResearchHER2/EGFR in Cancer ResearchGlycosylation and Glycoproteins ResearchImmune Cell Function and Interaction

Publications récentes

2026 articleOpenAlex

ABCL-753: A Phase 1/2, First-in-Human, Multicenter Study of DS3790, a CD37-Directed DXd Antibody-Drug Conjugate, in Patients With B-Cell Non-Hodgkin Lymphoma

Gilles Salles, Emmanuel Bachy, Franck Morschhauser, Pier Luigi Zinzani et autres

0 citationsClinical Lymphoma Myeloma & Leukemia

2026 articleOpenAlex

POSTER: TCL-416: Updated Clinical Data From the Phase 1/2 Study of Dibotatug (DR-01), a Non-Fucosylated Anti-CD94 Antibody, in Patients With Relapsed/Refractory Cytotoxic T/NK Cell Lymphomas

Swaminathan Iyer, Christina Poh, Jasmine Zain, Christiane Querfeld et autres

0 citationsClinical Lymphoma Myeloma & Leukemia

2026 conference-abstractOpenAlex

TCL-416: Updated Clinical Data From the Phase 1/2 Study of Dibotatug (DR-01), a Non-Fucosylated Anti-CD94 Antibody, in Patients With Relapsed/Refractory Cytotoxic T/NK Cell Lymphomas

Swaminathan Iyer, Christina Poh, Jasmine Zain, Christiane Querfeld et autres

0 citationsClinical Lymphoma Myeloma & Leukemia

2026 conference-abstractOpenAlex

TCL-839: A Multicenter, Open-Label, Phase 3 Randomized Trial of Duvelisib Versus Investigator's Choice (Gemcitabine or Bendamustine) in Relapsed/Refractory Nodal T-Cell Lymphoma With T-Follicular Helper Phenotype

Kate Cywnarski, Eva Domingo‐Doménech, David Sidransky, Ohad Bentur et autres

0 citationsClinical Lymphoma Myeloma & Leukemia

2026 articleOpenAlex

POSTER: ABCL-753: A Phase 1/2, First-in-Human, Multicenter Study of DS3790, a CD37-Directed DXd Antibody-Drug Conjugate, in Patients With B-Cell Non-Hodgkin Lymphoma

Gilles Salles, Emmanuel Bachy, Franck Morschhauser, Pier Luigi Zinzani et autres

0 citationsClinical Lymphoma Myeloma & Leukemia

2026 articleOpenAlex

POSTER: TCL-839: A Multicenter, Open-Label, Phase 3 Randomized Trial of Duvelisib Versus Investigator's Choice (Gemcitabine or Bendamustine) in Relapsed/Refractory Nodal T-Cell Lymphoma With T-Follicular Helper Phenotype

Kate Cywnarski, Eva Domingo‐Doménech, David Sidransky, Ohad Bentur et autres

0 citationsClinical Lymphoma Myeloma & Leukemia

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.